Preliminary results of a clinical trial of 4-phenylbutyrate (PBA) “show a significant reduction in seizure activity among participants.”

A new study in Nature identifies research strategies for tying brain function and structure to behavior and health.

Researchers introduce a biomarker to indicate whether someone is struggling with the inflexible thinking associated with the disorder.

Evaluating how genetic risk interacts with environmental risk factors such as sexual trauma is important for understanding how mental illness develops and identifying high-risk groups for early intervention.

Early detection opens the door to intervention via noninvasive neuromodulation for those with treatment-resistant symptoms of psychotic disorders like schizophrenia.

Bodien, who will co-direct the Neuroimaging Core of the Critical Illness, Brain Dysfunction and Survivorship Center, has applied behavioral measures and advanced neuroimaging to improve the diagnosis and prognosis of severe brain injury.

In 2008 at VUMC there were a group of doctors trying something unheard of on a handful of patients who signed up for their study. Half would receive deep brain stimulation (DBS) surgery in attempt to slow the progression of their early-stage Parkinson’s disease, and the others would not.